Date of management change: June 15, 2020
New York, NY-based Synaptogenix Appointed Alan Tuchman as Chief Executive Officer
Synaptogenix is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders.
Alan Tuchman is Chief Executive Officer at Synaptogenix. Previously, Alan held various senior HR leadership roles in the industry.
News
Short ProfileName: Alan Tuchman
Title: Chief Executive Officer
Company: Synaptogenix
Industry: Biotechnology
Current Contact InfoEmail: ********@synaptogen.com
Phone:.***.***.*00*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Wallace Sue, Lindemann Thomas, Chan Ryan, Norwood Dave, Cole Paul, Lawless Diana, Larrimer Karen, Forrest Qualenta, Lucchesi Viana, McDowell Jim, Shannon David
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
